# Savara Inc. (SVRA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $5.37, market value $1.1 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Savara Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 4293.1×**. Each dollar of revenue is priced at 4293.1×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 7.7×**. The shares trade at 7.7× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -10.0%** (5-yr avg -13.5%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -58.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -19.5%**. Return on all capital, debt included, is -19.5%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -19.6%**. Each dollar of assets produces -19.6% of profit.

## Growth
- **EPS growth (1 yr): -10.4%**. Earnings per share fell 10.4%.

## Financial health
- **Debt to equity: 0.15**. Debt is 0.15 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.1×**. It would take 0.1 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: -0.0×**. Operating profit covers interest only -0.0×: fragile.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Savara Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 50.0%** (YTD -10.9%, 3-mo 5.5%). The shares are up 50.0% over twelve months including dividends.
- **From 52-week high: -23.3%** (60.8% above the low). Trading 23% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 46**. An RSI of 46 is neutral.
- **Beta (1 yr): 1.24** (volatility 54%). Beta of 1.24 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SVRA · Page: https://foliofundamentals.com/stocks/svra

Not investment advice.